3. Respiratory System
| First line drugs | Second line drugs | Specialist drugs | Secondary care drugs |
| Recommended in both primary and secondary care | Alternatives (often in specific conditions) in both primary and secondary care; | Where a specialist input is needed (see introduction for definition) | Prescribing principally within secondary care only |
Traffic light status (TLS) explained:
- Green: Routine prescribing within licensed indication
- Amber 1: specialist recommendation followed by GP initiation and continuation
- Amber 2: specialist or GP initiation in line with local guideline after 1st line failure followed by GP continuation
- Amber 3: specialist initiation and stabilisation followed by GP continuation
- Amber SCG: specialist initiation and stabilisation followed by GP continuation in line with an agreed shared care guideline
- Red: Hospital or specialist prescribing only
- Double Red: These medicines have been evaluated and rejected by MKPAG and are NOT approved for use within MK. They are not recommended for use because of lack of clinical effectiveness, cost effectiveness or safety.
Contents
- 3.1 Airways disease, obstructive
- 3.2 Allergic conditions
- 3.3 Conditions affecting sputum viscosity
- 3.4 Cough and congestion
- 3.5 Idiopathic pulmonary fibrosis
- 3.6 Respiratory depression, respiratory distress syndrome and apnoea
Patient Counselling Resource
RightBreathe www.rightbreathe.com
- RightBreathe is a new website and application about inhaler devices launched on 20th February 2017. It has significant MI input and collaboration between multidisciplinary healthcare professionals.
- RightBreathe covers each and every inhaler and spacer device licensed in the UK for treating asthma and COPD. It presents specific, tailored information on each option in a standardised format and with assured quality.
- RightBreathe enables clinicians and patients to search and filter the options to suit individual circumstances and patients’ needs.
Appendices
- COPD Prescribing Guidelines (May 2019)
- COPD – First Line Inhaler Options (May 2019)
- Self Management of flare up COPD (June 2017)
- Prescribing Guidelines for the Management of Chronic Asthma (Adults) March 2017
- Management of Asthma and Diagnostic Algorithm (Adult) March 2017
- Categorisation of inhaled corticosteroids (ICS) by dose (Adults) March 2017
- Management of Acute Severe Asthma in Adults (Mar 2014)
- Bronchiecstasis leaflet June 2017
- Palliation of breathlessness in non–cancer conditions – guideline that accompany flowchart (July 2014)
- Palliation of breathlessness in non–cancer conditions – flowchart (July 2014)
Last updated by: Sheila Wood on 11-06-2019 12:20
-
BNF
-
NICE
-
Summary of product characteristics
